1.中华医学会健康管理学分会, 中华健康管理学杂志编委会, 中国健康管理协会健康服务机构质量管理分会, 等. 体检人群甲状腺结节风险评估与健康管理专家共识. 中华健康管理学杂志，2025,19(12):955-964.
2.Huang NS, Chen JY, Wei WJ, Hu JQ, Wang YJ, Liu WL, Guan Q, Sun TQ, Wang YL, Xiang J, Ji QH, Ji DM, Wang Y. Personalized treatment of 95 poorly differentiated thyroid cancer/anaplastic thyroid cancer in 2019-2023. Eur Thyroid J. 2025 Nov 5;14(6):e240371. doi: 10.1530/ETJ-24-0371. PMID: 41104970; PMCID: PMC12598928.
3.Zhang T, Cui W, Tang H .Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer Cell Reports Medicine, 2026; 7
4.王东梅,周茜,霍煜廷,于双,王淑荣.甲状腺结节的影响因素研究进展[J].中国普通外科杂志,2018,27(05):635-641.
5.Cao SL, Wang SR, Kim JH, et al. International expert consensus on thermal ablation for benign thyroid nodules (2025 Edition). Int J Surg 2026;00:1-15.
6.Durante C, Hegedüs L, Czarniecka A, et al. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. Eur Thyroid J 2023;12(5):e230067
